Koninklijke Philips (NYSE:PHG) Receives Consensus Rating of “Moderate Buy” from Brokerages

Koninklijke Philips (NYSE:PHG) has earned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company.

Several equities research analysts recently weighed in on PHG shares. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th. Finally, UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th.

Institutional Trading of Koninklijke Philips

Several large investors have recently modified their holdings of the company. PNC Financial Services Group Inc. increased its position in shares of Koninklijke Philips by 4.8% during the 3rd quarter. PNC Financial Services Group Inc. now owns 36,291 shares of the technology company’s stock valued at $1,187,000 after purchasing an additional 1,676 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Koninklijke Philips by 26.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 55,290 shares of the technology company’s stock valued at $1,809,000 after buying an additional 11,538 shares during the period. Cerity Partners LLC increased its holdings in Koninklijke Philips by 16.8% during the third quarter. Cerity Partners LLC now owns 60,112 shares of the technology company’s stock valued at $1,967,000 after buying an additional 8,625 shares during the last quarter. Pitcairn Co. bought a new position in Koninklijke Philips in the third quarter worth approximately $256,000. Finally, Bank of Montreal Can boosted its stake in shares of Koninklijke Philips by 2,883.5% during the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after acquiring an additional 949,278 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 2.2 %

Koninklijke Philips stock opened at $25.70 on Friday. Koninklijke Philips has a 12 month low of $19.10 and a 12 month high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The business’s fifty day simple moving average is $26.73 and its two-hundred day simple moving average is $27.61. The company has a market capitalization of $24.15 billion, a price-to-earnings ratio of -30.59, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The firm had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. As a group, equities analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s payout ratio is -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.